Pentomone

Pentomone

Clinical data
Other names	Lilly 113935; LY-113935
Drug class	Nonsteroidal antiandrogen
ATC code	None
Identifiers
IUPAC name (5aS,6aR,12aS,13aR)-4,8-dimethoxy-6,6-dimethyl-5a,6a,12,12a,13a,14-hexahydrochromeno[3,2-b]xanthen-13-one
CAS Number	67102-87-8
PubChem CID	49354
ChemSpider	44862
UNII	OPS67T329P
ChEMBL	ChEMBL2107005
Chemical and physical data
Formula	C24H26O5
Molar mass	394.467 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC1(C2C(CC3=C(O2)C(=CC=C3)OC)C(=O)C4C1OC5=C(C4)C=CC=C5OC)C
InChI InChI=InChI=1S/C24H26O5/c1-24(2)22-15(11-13-7-5-9-17(26-3)20(13)28-22)19(25)16-12-14-8-6-10-18(27-4)21(14)29-23(16)24/h5-10,15-16,22-23H,11-12H2,1-4H3/t15-,16+,22-,23+ Key:MTJTVTZUEKVNTG-YJEDKTMASA-N

Pentomone (INN, USAN) (developmental code name Lilly 113935 or LY-113935) is a nonsteroidal antiandrogen (NSAA) described as a "prostate growth inhibitor" which was never marketed. It was synthesized and assayed in 1978.